ScholarIQanswers from OpenAlex

The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors

PaperCitations, authors & open-access status

The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors is a paper indexed in ScholarIQ from OpenAlex.

How many citations does The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors have?

ScholarIQcitation count

The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors has 1,690 citations in the OpenAlex counts ScholarIQ stores.

When was The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors published?

ScholarIQyear

The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors has 2012 year in the ScholarIQ index.

What is the open-access status of The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors?

ScholarIQoa status

The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors has bronze oa status in the ScholarIQ index.

What is the DOI of The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors?

ScholarIQdoi

The DOI for The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors is on the source record.

What is the PMID of The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors?

ScholarIQpmid

The PMID for The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors is on the source record.

What is the OpenAlex record for The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors?

ScholarIQopenalex

The OpenAlex for The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial